title: [SUVmax measured by 18F FDG PET/CT in the primary tumor in relation to clinical and pathological features of endometrial cancer].
abstract: OBJECTIVE
  The aim of the study was to determine the value of SUVmax by PET/CT measured before surgery with special focus on FIGO stage, myometrial invasion, grading and risk stratification.
  
  
  METHODS
  A total of 90 women, aged 37-84 (mean 65.1 +/- 9.5) with endometrial cancer (FIGO I and II) underwent 18F FDG PET/CT imaging before surgery SUVmax of the primary tumor was assessed and compared with histological prognostic factors (FIGO stage, grading, myometrial invasion, risk group).
  
  
  RESULTS
  The mean SUVmax in the study group was 13.95 +/- 5.49. SUVmax was significantly higher with high FIGO stage (p=0,0009), deep myometrial invasion (p=0.0005), high grade (p=0.0331) and high risk tumors (0.0007). Patients with the poor prognosis had significantly higher SUVmax values.
  
  
  CONCLUSIONS
  The preoperative SUVmax measurements of the primary tumor of endometrial cancer may give additional clinical and prognostic information about risk factors and poor prognosis. High value of SUVmax might be useful in making noninvasive diagnoses and deciding the appropriate therapeutic strategy for patients with endometrial cancer However there is not enough evidence that it could in fact replace surgical staging.
authors.affiliation: Katedra Połoznictwa, Chorób Kobiecych i Ginekologii Onkologicznej, Collegium Medicum w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruni, Polska. walentowiczm@cm.umk.pl
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Walentowicz-Sadłecka
authors.forename: Paweł
authors.initials: P
authors.lastname: Sadłecki
authors.forename: Bogdan
authors.initials: B
authors.lastname: Małecki
authors.forename: Paweł
authors.initials: P
authors.lastname: Walentowicz
authors.forename: Andrzej
authors.initials: A
authors.lastname: Marszałek
authors.forename: Piotr
authors.initials: P
authors.lastname: Domaracki
authors.forename: Marek
authors.initials: M
authors.lastname: Grabiec
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016889:Endometrial Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology* / Q000601:surgery; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008875:Middle Aged; D064847:Multimodal Imaging / Q000379:methods; D009367:Neoplasm Staging; D011044:Poland; D011237:Predictive Value of Tests; D011379:Prognosis; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D047368:Tumor Burden; D016387:Women's Health
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18